P1636: PATIENT PREFERENCES AND EXPERIENCES REGARDING THROMBOPOIETIN-RECEPTOR AGONISTS FOR IMMUNE THROMBOCYTOPENIA IN THE NETHERLANDS (TRAPEZE NL STUDY).
A. G. Jansen,
V. McDonald,
A. Newland,
M. Morgan,
S. Visser-Peereboom,
K. Wilson,
D. Eriksson,
E. Geldman,
O. Daykin-Pont,
J. J. Zwaginga
Affiliations
A. G. Jansen
1 Department of Haematology, Erasmus MC, Rotterdam, Netherlands
V. McDonald
2 Department of Clinical Haematology, The Royal London Hospital, Barts Health NHS Trust
A. Newland
3 Academic Haematology Unit, Blizzard institute, Barts & The London School of Medicine & Dentistry, Queen Mary Institute of London, London
M. Morgan
4 ITP Support Association, Bolnhurst, United Kingdom
S. Visser-Peereboom
5 Swedish Orphan Biovitrum AB, Stockholm, Sweden
K. Wilson
5 Swedish Orphan Biovitrum AB, Stockholm, Sweden
D. Eriksson
5 Swedish Orphan Biovitrum AB, Stockholm, Sweden
E. Geldman
6 Wickenstones Ltd, Abingdon, United Kingdom
O. Daykin-Pont
6 Wickenstones Ltd, Abingdon, United Kingdom
J. J. Zwaginga
7 Department of Haematology, Leiden University Medical Centre, Leiden, Netherlands
